Danshen-Chuanxiongqin Injection attenuates cerebral ischemic stroke by inhibiting neuroinflammation

来源 :中国天然药物 | 被引量 : 0次 | 上传用户:snelgar
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Danshen-Chuanxiongqin Injection(DCI)is a commonly used traditional Chinese medicine for the treatment of cereb-ral ischemic stroke in China.However,its underlying mechanisms remain completely understood.The current study was designed to explore the protective mechanisms of DCI against cerebral ischemic stroke through integrating whole-transcriptome sequencing coupled with network pharmacology analysis.First,using a mouse model of cerebral ischemic stroke by transient middle cerebral artery occlusion(tMCAO),we found that DCI(4.10 mL·kg-1)significantly alleviated cerebral ischemic infarction,neurological defi-cits,and the pathological injury of hippocampal and cortical neurons in mice.Next,the whole-transcriptome sequencing was per-formed on brain tissues.The cerebral ischemia disease(CID)network was constructed by integrating transcriptome sequencing data and cerebrovascular disease-related genes.The results showed CID network was imbalanced due to tMCAO,but a recovery regulation was observed after DCI treatment.Pathway analysis of the key genes with recovery efficiency showed that the neuroinflammation sig-naling pathway was highly enriched,while the TLR2/TLR4-MyD88-NF-κB pathway was predicted to be affected.Consistently,the in vivo validation experiments confirmed that DCI exhibited protective effects against cerebral ischemic stroke by inhibiting neuroinflam-mation via the TLR2/TLR4-MyD88-NF-κB pathway.More interestingly,DCI markedly suppressed the neutrophils infiltrated into the brain parenchyma via the choroid plexus route and showed anti-neuroinflammation effects.In conclusion,our results provide depend-able evidence that inhibiting neuroinflammation via the TLR2/TLR4-MyD88-NF-κB pathway is the main mechanism of DCI against cerebral ischemic stroke in mice.
其他文献
动态血糖监测(CGM)技术迅速发展,已成为DM管理的重要方法.规范合理应用CGM系统可明显降低DM患者HbA1c水平,减少血糖波动及低血糖风险,提高血糖控制效果和生活质量,对改善DM患者预后意义重大.本文对CGM技术与临床研究进展进行综述.
中南大学湘雅二医院国家代谢性疾病临床医学研究中心、中国民族卫生协会、《糖尿病天地》杂志社共同主办的“第十六届湘雅国际糖尿病免疫学论坛”(以下简称“论坛”)于2021年4月23~25日在湖南长沙举行.
期刊
一、Ins治疗现状及挑战rn中国DM患者负担沉重,约占全球DM患者的1/4[1].尽管DM防控工作取得一定进步,但我国仍有50. 6%的T2DM患者未能实现良好的血糖控制[2].DM作为一种进展性疾病[3],起始Ins治疗是疾病管理的必经阶段[4].基础胰岛素方案是国内外指南[5-6]共同推荐的Ins起始方案,且一旦起始基础胰岛素治疗,为实现良好的血糖控制,对Ins剂量的合理调整十分必要.
期刊
Physalin B(PB),one of the major active steroidal constituents of Solanaceae Physalis plants,has a wide variety of bio-logical activities.We found that PB significantly down-regulated β-amyloid(Aβ)secretion in N2a/APPsw cells.However,the underly-ing mechan
During the pathogensis of rheumatoid arthritis(RA),activated RA fibroblast-like synoviocytes(RA-FLSs)combines similar proliferative features as tumor and inflammatory features as osteoarthritis,which eventually leads to joint erosion.Therefore,it is imper
Ocotillol(OT)-type ginsenosides,one subtype of ginsenosides,consist of a dammarane skeleton and a tetrahydrofuiran ring.Most naturally-occurring OT-type ginsenosides exist in Panax species,particularly in Panax quinquefolius,which may be attrib-uted to th
Sargassum fusiforme(S.fusiforme)has been used as an ingredient in Chinese herbal medicine for thousands of years.However,there are a limited number of studies concerning its therapeutic mechanism.High performance gel permeation chromato-graphy(HPGPC)analy
Berberis amurensis(Berberidaceae)is a traditional Chinese medicine,which is often used to treat hypertension,in-flammation,dysentery and enteritis.It contains alkaloids,mainly including berberine,berbamine,magnoflorine,jatrorrhizine and pal-matine.Berberi
Tripterygium wilfordii multiglycoside(GTW)is a commonly used compound for the treatment of rheumatoid arthritis(RA)and immune diseases in clinical practice.However,it can induce liver injury and the mechanism of hepatotoxicity is still not clear.This stud
The first-generation taxanes(including paclitaxel and docetaxel)are widely used for the treatment of various cancers in clinical settings.In the past decade,a series of new-generation taxanes have been developed which are effective in the inhibition of tu